Figures & data
Table 1 Whitehead’s principal determinants of health disparities and COPD correlates
Table 2 Relationship between socioeconomic status and respiratory measures
Table 3 Relationship between socioeconomic status and COPD prevalence
Table 4 Effect of socioeconomic status on respiratory-related outcomes in chronic obstructive pulmonary disease
Figure 1 All-cause mortality rate by socioeconomic status among COPD patients in Canada from 1996/1997 to 2011/2012.
Abbreviation: COPD, chronic obstructive pulmonary disease.
![Figure 1 All-cause mortality rate by socioeconomic status among COPD patients in Canada from 1996/1997 to 2011/2012.](/cms/asset/9fb6c211-22a6-4f7f-b0d1-d34f9abbe537/dcop_a_79077_f0001_c.jpg)
Figure 2 World Health Organization drug therapy guidelines for managing acute exacerbations of COPD and stable management in resource limited settings.
Abbreviations: ADRs, adverse drug reactions; AECOPD, acute exacerbation of COPD; COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; ICS, inhaled corticosteroid; IV, intravenous.
![Figure 2 World Health Organization drug therapy guidelines for managing acute exacerbations of COPD and stable management in resource limited settings.](/cms/asset/f93ab70d-a82b-4b3b-9e5f-36346bffffca/dcop_a_79077_f0002_b.jpg)
Table 5 Drug costs relative to days of work in low-income people in the US